Li et al. [33] revealed that silencing of lncRNA PRRT3-AS1 could activate the expression of the PPARγ gene and then block the mTOR signaling pathway to inhibit prostate cancer cell proliferation and promote apoptosis and autophagy. Here, PPARG is linked to prostate carcinoma.